期刊文献+

中老年男性体质指数与血清前列腺抗原的关系 被引量:2

Study on the relationship between BMI and serum prostate specific antigen in middle and old aged males
原文传递
导出
摘要 目的探讨上海市中老年男性血清前列腺特异抗原(PSA)与体质指数(BMI)的关系,评价根据BMI水平制订不同的PSA界值的必要性。方法随机选取于2010年1-7月参加上海市科学技术委员会资助项目的 591名40岁及以上、无前列腺癌史的男性作为研究对象。通过问卷调查获取调查对象的一般人口学特征、患病及用药情况。采用国际前列腺症状分数(IPSS)判断男性排尿障碍程度。对调查对象进行体格检查和前列腺B超检查,采集清晨空腹静脉血检测PSA值。采用一般线性模型及偏相关分析,探讨BMI与PSA的关系。结果调查对象年龄40~77岁,平均(58.5±7.2)岁。调整年龄,是否使用阿司匹林、利尿剂及其他抗炎药,是否有糖尿病、IPSS评分及前列腺体积(连续性变量)等混杂因素后,BMI<24、24~、≥28kg/m2的男性PSA的几何均数分别为1.01ng/ml(95%CI:0.89~1.16ng/ml)、0.84ng/ml(95%CI:0.75~0.95ng/ml)和0.77ng/m(l95%CI:0.66~0.90ng/ml)。BMI与血清PSA水平呈负相关(r=-0.158,P<0.01)。结论采用PSA值评估前列腺癌患病风险时应当考虑BMI对PSA值的影响。 Objective To explore the association between body mass index(BMI) and serum prostate specific antigen(PSA) level and to evaluate whether different PSA thresholds based on BMI were needed.Methods The subjects of present study were 591 men(≥40 years old) without a history of prostate cancer,who participated in a project funded by Shanghai Science and Technology from January to July in 2010.The demographic,anthropometric and medical history data were collected by interview.The male urinary dysfunction was assessed with the International Prostate Symptom Score(IPSS).The prostates were measured by ultrasonography and serum PSA levels were determined in all subjects.General linear regression and partial correlation coefficient were used to evaluate the relationship between BMI and PSA levels.Results The mean age of subjects was(58.5±7.2) years old(40~70 years old).After adjusting age,use of drugs(Aspirin,uretic and other anti-inflammatory drugs),diabetes,IPSS scores and prostate volumes(continuous variable) of subjects,the mean geometric PSA levels in subjects with different BMI levels(BMI24 kg/m 2,24 kg/m 2 ≤BMI28 kg/m 2,and BMI≥28 kg/m 2) were 1.01 ng/ml(95%CI:0.89~1.16 ng/ml),0.84 ng/ml(95%CI:0.75~0.95 ng/ml) and 0.77 ng/ml(95%CI:0.66~0.90 ng/ml),respectively.There was a negative correlation between BMI and PSA levels(r=-0.158,P0.01).Conclusion When PSA level is used to assess the risk of prostate cancer,the effect of BMI on PSA level should be considered.
出处 《中国慢性病预防与控制》 CAS 2013年第4期406-408,共3页 Chinese Journal of Prevention and Control of Chronic Diseases
基金 上海市科委重大科研基金(09DJ1400400)
关键词 中老年 男性 前列腺特异抗原 体质指数 Middle and old-aged Men Prostate specific antigen Body mass index
  • 相关文献

参考文献11

  • 1叶定伟,李长岭.前列腺癌发病趋势的回顾和展望[J].中国癌症杂志,2007,17(3):177-180. 被引量:119
  • 2毕红琳.按年龄分层设定PSA在前列腺癌诊断中的诊断界值的意义探讨[J].现代检验医学杂志,2011,26(1):90-91. 被引量:4
  • 3Fukui M, Tanaka M, Kadono M, et al. Serum prostate-specific antigen levels in men with type 2 diabetes [ J ]. Diabetes Care ,2008, 31 (5): 930-931.
  • 4Linton HJ, Marks LS, Millar LS, et al. Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease [ J ]. Clin Chem, 2003,49(2):253-259.
  • 5Kristal AR, Chi C, Tangen CM,et al. Associations of dempgraphic and lifestyle characteristics with prostate specific antigen (PSA) concentra- tion and rate of PSA increase[J]. Cancer,2006,106(2):320-328.
  • 6Capitanio U, Perrotte P, Hutterer GC, et al. Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1 490 men [ J ]. Int J Uro1,2009, 16( 1 ):91-95.
  • 7Wright JL, Lin DW, Stanford JL. The effect of demographic and clinical factors on the relationship between BMI and PSA levels[J ]. Prostate, 2011.71( 15):1631-1637.
  • 8中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[M],北京:人民卫生出版社,2006,1-20.
  • 9谢立平,秦杰,郑祥毅,沈华峰,陈昭典,蔡松良,张志根,丁伟,任国平,王丽君,余心如.481例前列腺癌患者年龄与病理构成分析[J].中华男科学杂志,2005,11(6):428-430. 被引量:36
  • 10Rodriquez C, Freedland SJ, Deka A, et al. Body mass index, weight change, and risk of prostate cancer in the cancer prevention study II nutrition cohort[J ].Cancer Epidemiol Biomarkers Prey,2007,16( 1 ):63-59.

二级参考文献19

  • 1邵常霞,项永兵,刘振伟,高静,孙璐,方茹蓉,阮志贤,高立峰,金凡,高玉堂.上海市区泌尿系统恶性肿瘤相对生存率分析[J].中国肿瘤临床,2005,32(6):321-324. 被引量:31
  • 2叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 3Denmeade SR,Isaacs JT. The role of prostate-specif- ic antigen in the clinical evaluation of prostatic dis- ease[J]. BJU 1nt,2007,93(Suppl 1) :10-15.
  • 4Yang CR,Su CK,Chiu KY,et al. Free/total prostate specific antigen ratio for prostate cancer detection:a prospective blind study[J]. Anticancer Res, 2005, 25 (30) : 2439-2443.
  • 5Lemer SE, facobsen S J, Lilja H, et al. Free, comple- xed ,and total serum prostate-specific antigen concen- tration and their proportions in predicting stage, grade,and deoxyribo,conucleic acid ploidy in patients with adenocarcinoma of the prostate [J]. Urology, 1996,48 (2) : 240-248.
  • 6Tanguay S, Begin LR, Elhilali MM, et al. Compara- tive evaluation of total PSA, free/total PSA, and complexed PSA in prostate cancer detection [J]. Urol, 2002,59 (2) : 261-265.
  • 7Parker SL, Tong T, Bolden S ,et al. Cancer statistics, 1996[J]. CA Cancer J Clin, 1996,46(1)15-27.
  • 8Brawley OW, Barnes S. The epidemiology of prostate cancer in the United States[J]. Semin Oncol Nurs, 2001, 17(2) :72-77.
  • 9沃尔森.坎贝尔泌尿外科学[M].北京:科学出版社,2001.2487-2495.
  • 10Smith RA, Cokkinides V, Eyre HJ. American Cancer Society. American Cancer Society guidelines for the early detection of cancer, 2003 [J]. CA Cancer J Clin, 2003, 53 ( 1 ) :27-43.

共引文献410

同被引文献16

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部